Package 1
This tender has been awarded
Awarded to Asclepios S.A.; Amgen Sp. z o.o.; Sanofi Sp. z o.o.; Komtur Polska Sp. z o.o.; Roche Polska Sp. z o.o. — €10,216,828
About This Opportunity
TranslatedThis tender refers to "Package 1" and specifies a pharmaceutical product: "1 Crisantaspasum 10000 IU/vial powder for solution for injection x 5 vials." A critical requirement is the "on-call" delivery within 8 hours (Wymagana dostawa "na Ratunek" w ciągu 8h). Additionally, the preparation is approved for use in children, with dosage dependent on body weight (Preparat dopuszczony do stosowania u dzieci w dawce zależnej od masy ciała). The product code is OP 5. Crisantaspasum is likely a specific brand or type of medication, possibly an enzyme or therapeutic agent. The urgent delivery requirement suggests this is for critical care or emergency situations where rapid access to medication is essential. The approval for pediatric use indicates its applicability across different age groups, though dosage must be carefully managed based on weight. This tender is likely issued by a hospital pharmacy, emergency medical service, or a healthcare facility requiring a rapid and reliable supply of this specific medication for critical or pediatric patients. Bidders must confirm their ability to meet the stringent 8-hour delivery deadline and provide the specified pharmaceutical product in compliance with all quality and regulatory standards.
This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: Polish1 Crisantaspasum 10000 j.m./fiolkę proszek do sporz. roztw. do wstrzyk. x 5 fiol. *Wymagana dostawa "na Ratunek" w ciągu 8h *Preparat dopuszczony do stosowania u dzieci w dawce zależnej od masy ciała OP 5
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 23, 2026. Last refreshed 35 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku
Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku has issued 63 procurement notices on BidsFactory, including 4 currently open and 47 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU) and Poland e-Zamówienia. Most recent publication: June 1, 2026.
Frequently asked questions about this tender
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Asclepios S.A.; Amgen Sp. z o.o.; Sanofi Sp. z o.o.; Komtur Polska Sp. z o.o.; Roche Polska Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
Asclepios S.A.; Amgen Sp. z o.o.; Sanofi Sp. z o.o.; Komtur Polska Sp. z o.o.; Roche Polska Sp. z o.o. was awarded the contract for €10,216,828. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.
Sectors & Categories
Contracting Authority
Contact
Companies That Won Similar
Companies with awards in Health & Medical in Poland